• 제목/요약/키워드: DA-8159

검색결과 27건 처리시간 0.029초

Induction of penile erection in spinal cord-injured rabbits by administration of DA- 8159, a new selective PDE 5 inhibitor

  • Ahn, Gook-Jun;Kang, Kyung-Koo;Back, Dae-Hyun;Sohn, Yong-Sung;Choi, Seul-Min;Ahn, Byung-Ok;Kwon, Jong-Won;Kim, Won-Bae
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.250.2-251
    • /
    • 2002
  • DA-8159 is a new. highly selective. potent cyclic-GMP phosphodiesterase 5 inhibitor developed by Dong-A Pharmaceutical Company(Kyunggi, Korea) as an oral drug for the treatment of erectile dysfunction. NO- cGMP signal transduction pathway plays a key role for relaxation of corpus cavernosal smooth muscle. In this study. the efficacy of DA-8159 was evaluated by measuring the length of uncovered penile mucosa in spinal cord injury(SCI) rabbits. (omitted)

  • PDF

Attenuation of monocrotaline-induced pulmonary hypertension with DA-8159, a potent PDE 5 inhibitor

  • Ahn, Gook-Jun;Kang, Kyung-Koo;Sohn, Yong-Sung;Choi, Seu-Min;Kim, Ju-Mi;Kim, Dong-Hwan;Ahn, Byoung-Ok;Kim, Won-Bae
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.249.1-249.1
    • /
    • 2002
  • This study was carried out to demonstrate the effects of oral administration of DA-8159. a selective phosphodiesterase 5 inhibitor. on development of pulmonary hypertension induced by monocrotaline (MCT). MCT-treated rats(60mg/kg) were divided into three groups and orally administered vehicle, 1 mg/kg or 5 mg/kgg of DA-8159 twice a day for 3 weeks. Increased right ventricular weights, medial wall thickening in pulmonary arteries. myocardial fibrosis, decrease of plasma cyclic guanosine monophosphate (cGMP) level and body weight gains were shown in MCT group. (omitted)

  • PDF

Carcinogenicity : a Case Study of DA-8159

  • Ahn, Byoung-Ok
    • 한국환경성돌연변이발암원학회:학술대회논문집
    • /
    • 한국환경성돌연변이발암원학회 2004년도 KSOT/KEMS Fall Annual Meeting
    • /
    • pp.90-95
    • /
    • 2004
  • PDF

PRECLINICAL TOXICITY STUDY OF A NEW PHOSPHODIESTERASE-5 INHIBITOR (II) FOUR-WEEK SUBACUTE TOXICITY STUDY IN RATS

  • Hyeon Cho;Kim, Dong-Hwan;Kang, Kyung-Koo;Ahn, Byoung-Ok;Kim, Won-Bae
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 2001년도 International Symposium on Signal transduction in Toxicology
    • /
    • pp.128-128
    • /
    • 2001
  • Toxic effects of a new phosphodiesterse-5 inhibitor, DA-8159, were investigated in Sprague-Dawley rats by repeated oral administration. Four groups of 10 male and 10 female rats were treated with DA-8159 at a dose of 0, 40, 80, or 320 mg/kg/day for 4 weeks.(omitted)

  • PDF

RECLINICAL TOXICITY STUDY OF A NEW PHOSPHODIESTERASE-5 INHIBITOR (I) ACUTE TOXICITY STUDY AND MUTAGENICITY

  • Kim, Dong-Hwan;Hyeon Cho;Kang, Kyung-Koo;Ahn, Byoung-Ok;Kim, Won-Bae
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 2001년도 International Symposium on Signal transduction in Toxicology
    • /
    • pp.127-127
    • /
    • 2001
  • Single-dose toxicity of a new phosphodiesterse inhibitor-5, DA -8159, was studied in rats via oral and intravenous routes and in mice via oral route. In addition, genotoxic potential of DA-8159 was investigated by using of the battery of test; reverse mutation test on bacteria, chromosomal aberration test on cultured mammalian cells and micronucleous test on mice.(omitted)

  • PDF